Renaissance Technologies
CMTA

Renaissance Technologies’s Clementia Pharmaceuticals Inc. CMTA Stock Holding History

Renaissance Technologies’s Portfolio CMTA Stock Details CMTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-11,700
Closed -$305K – 3884
2019
Q1 		$305K Buy
+11,700
New +$219K ﹤0.01% 3087

Renaissance Technologies's CMTA Position: Q2 2019 in Review

Renaissance Technologies sold out of Clementia Pharmaceuticals Inc. (CMTA) in Q2 2019, closing a stake of 11,700 shares — an estimated $305K sold.

Renaissance Technologies first reported a position in CMTA in Q1 2019 and held it in 1 quarter. The position peaked at $305K in Q1 2019. 0 funds tracked by Wall St. Rank hold CMTA as of Q2 2019.

  • Renaissance Technologies reported no remaining Clementia Pharmaceuticals Inc. position as of Q2 2019 after selling out during the quarter.
  • Renaissance Technologies sold 11,700 Clementia Pharmaceuticals Inc. shares in Q2 2019, an estimated $305K.
  • Renaissance Technologies first reported a position in Clementia Pharmaceuticals Inc. in Q1 2019 and held it in 1 quarter.
  • Renaissance Technologies's Clementia Pharmaceuticals Inc. position peaked at $305K in Q1 2019.
  • 0 funds tracked by Wall St. Rank held Clementia Pharmaceuticals Inc. as of Q2 2019.

Based on Renaissance Technologies's 13F filing for Q2 2019, filed 12 Aug 2019.